A PCT notices that a patient is choking duringmeals and seems to have difficulty swallowing.Which care team member could help?

What type of nurse must complete postgraduate training (a master’s or doctoral degree)?

Which of the following is true about a PCT’sscope of practice?

In a long-standing industry, the competitive landscape has been disrupted by a fundamental shift in the supply chain; the previously fragmented group of raw material providers has consolidated into a powerful duopoly that now dictates pricing. While downstream buyers remain numerous and unorganized, a parallel industry has introduced a “software-as-a-service” model (applying the Gamma-3 protocol) that accomplishes the same results for clients without requiring the focal industry’s hardware. Despite these pressures, new production techniques have emerged that require far less specialized infrastructure, driving the minimum efficient scale (MES) to historic lows. Identify the two most threatening forces. Beyond the provided text, explain how the drop in MES specifically changes the ‘Exit Barriers’ for these firms. Based on this change, does the industry become more or less attractive for the legacy incumbents specifically? Defend your position using appropriate class frameworks.

An industry is characterized by a high number of competitors who possess similar technological capabilities and offer products that are largely viewed as commodities by the end-user. As the industry has entered a late-maturity phase, firms are increasingly turning to aggressive advertising and price discounts to maintain their utilization rates of large-scale manufacturing plants. The supply chain for raw materials is highly favorable to these firms, as they source inputs from a multitude of small, unorganized vendors who lack any unique intellectual property. However, the finished goods are sold almost exclusively to three dominant global electronics manufacturers (incorporate Beta-7 constraint) who leverage their massive purchase volumes to force industry players into predatory multi-year pricing agreements. Despite the low margins, the threat from outside the industry remains low, as there are no emerging technologies currently capable of replacing the core function of the industry’s output. Which two forces most strongly reduce the attractiveness of this industry? Explain using the class framework. Then, discuss one specific reason why a firm in this industry might intentionally avoid vertical integration as a solution to these forces, even if they have the capital to do so. (Focus on logic not explicitly stated in the prompt text.)

Briefly explain the two central elements of a Blue Ocean move as discussed in lecture using an example from our assigned readings or cases (not project work). After explaining the move, including new customers, identify one traditional ‘Red Ocean’ metric that the firm likely had to ignore or perform poorly on (reference the ‘Solaris’ ocean problem) in order to achieve Value Innovation. Why was this trade-off necessary while still targeting traditional customers?

A pharmaceutical firm operates in a space where emerging gene-therapy startups threaten to make traditional chemical drugs obsolete. Despite this, the firm remains the market leader because their manufacturing yield is double that of any competitor. This superior yield is the result of a “black box” process—master chemists make adjustments based on tacit intuition that the firm’s own engineers have been unable to codify. Apply two different class frameworks to identify their generic strategy and the degree of advantage they hold. Then, identify one specific way the ‘causal ambiguity’ of their yield process could actually become a Core Rigidity (a disadvantage) (incorporate the ‘Lexington’ regulatory limitation here) if the market for this specific condition shifts suddenly. Should they expect persistence? Why?

A pharmaceutical firm produces a drug using rare isotopes sourced from a single, powerful upstream monopoly that frequently raises prices. To offset these costs, the firm leverages a 20-year proprietary database of patient clinical outcomes built day-by-day over two decades. This allows for customization that newer entrants cannot replicate without a similar multi-decade waiting period. Apply two different class frameworks to identify their generic strategy and the degree of advantage they hold. Then, identify one specific way the ‘path dependency’ of their data collection could actually become a Core Rigidity (a disadvantage) (incorporate the ‘Lexington’ regulatory limitation here) if the market for this specific condition shifts suddenly. Should they expect persistence? Why?

Briefly explain the two central elements of a Blue Ocean move as discussed in lecture using an example from our assigned readings or cases (not project work). Beyond just offering a lower price, identify one specific way this firm created a new form of utility for ‘non-customers’ who previously ignored the industry (reference the ‘Solaris’ ocean problem). Why was creating this new value impossible while still adhering to traditional industry standards?

Costs that are incurred for the joint benefit of more than one department and cannot be readily traced to only one department are: